Stock Scorecard
Stock Summary for Clover Health Investments Corp - Class A (CLOV)
Total Score
14 out of 29
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for CLOV
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CLOV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CLOV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for CLOV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Financial Details for CLOV
Company Overview |
|
|---|---|
| Company Name | Clover Health Investments Corp - Class A |
| Country | USA |
| Description | Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee. |
| Sector Name | FINANCE |
| Industry Name | HOSPITAL & MEDICAL SERVICE PLANS |
| Most Recent Quarter | 9/30/2022 |
| Next Earnings Date | 2/21/2023 |
Stock Price History |
|
| Last Day Price | 1.36 |
| Last Day Volume | 0 |
| Average Daily Volume | 7,054,917 |
| 52-Week High | 4.80 |
| 52-Week Low | 1.21 |
| Last Price to 52 Week Low | 12.40 % |
Valuation Measures |
|
| Trailing PE | 0.00 |
| Industry PE | 24.04 |
| Sector PE | 25.68 |
| 5-Year Average PE | -5.59 |
| Free Cash Flow Ratio | 0.73 |
| Industry Free Cash Flow Ratio | 6.46 |
| Sector Free Cash Flow Ratio | 14.33 |
| Book Value Per Share Most Recent Quarter | 0.82 |
| Price to Book Ratio | 1.50 |
| Industry Price to Book Ratio | 4.23 |
| Sector Price to Book Ratio | 2.53 |
| Price to Sales Ratio Twelve Trailing Months | 0.21 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.79 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.81 |
Share Statistics |
|
| Total Shares Outstanding | 383,549,000 |
| Market Capitalization | 521,626,640 |
| Institutional Ownership | 0.00 % |
Dividends |
|
| Ex-Dividend Date | |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00 % |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00 % |
| 5-Year Average Dividend Yield | 0.00 % |
| 5-Year Dividend Payments Count | 0 |
| Dividend Payout Ratio | 0.00 % |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00 % |
| Annual Earnings Growth | -330.93 % |
| Reported EPS Past Year | -0.54 |
| Reported EPS Prior Year | -1.27 |
| Net Income Twelve Trailing Months | -441,999,000 |
| Net Income Past Year | -587,756,000 |
| Net Income Prior Year | -136,392,000 |
| Quarterly Revenue Growth YOY | 117.40 % |
| 5-Year Revenue Growth | 118.76 % |
Balance Sheet |
|
| Total Cash Per Share | 1.86 |
| Total Cash Most Recent Quarter | 711,784,000 |
| Total Cash Past Year | 615,255,000 |
| Total Cash Prior Year | 28,003,240 |
| Net Cash Position Most Recent Quarter | 691,784,000 |
| Net Cash Position Past Year | 595,255,000 |
| Long Term Debt Past Year | 20,000,000 |
| Long Term Debt Prior Year | 20,803,000 |
| Total Debt Most Recent Quarter | 20,000,000 |
| Equity to Debt Ratio Past Year | 0.96 |
| Equity to Debt Ratio Most Recent Quarter | 0.95 |
| Current Ratio Most Recent Quarter | 1.29 |
| Total Stockholder Equity Past Year | 535,414,000 |
| Total Stockholder Equity Prior Year | 5,000,007 |
| Total Stockholder Equity Most Recent Quarter | 391,980,000 |
Options |
|
| Put/Call Ratio | 0.07 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| MACD | -0.10 |
| MACD Signal | -0.10 |
| 20-Day Bollinger Lower Band | 2.09 |
| 20-Day Bollinger Middle Band | 2.52 |
| 20-Day Bollinger Upper Band | 2.95 |
| Beta | 1.95 |
| RSI | 42.50 |
| 50-Day SMA | 2.55 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 12/3/2022 4:24:10 AM |